Radioprotection of Normal Tissue to Improve Radiotherapy: The Effect of the Bowman Birk Protease Inhibitor

E-ISSN： 1875-5968|3|5|360-363

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.3, Iss.5, 2003-09, pp. : 360-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes

By Dittmann K. Virsik-köpp P. Mayer C. Rave-Fränk M. Rodemann H. P.

International Journal of Radiation Biology, Vol. 79, Iss. 10, 2003-10 ,pp. : 801-808

Informa Healthcare

Access to resources Recommend Favorite

Bowman-Birk protease inhibitor reduces the radiation-induced activation of the EGF receptor and induces tyrosine phosphatase activity

By Gueven N. Dittmann K. Mayer C. Rodemann H. P.

International Journal of Radiation Biology, Vol. 73, Iss. 2, 1998-02 ,pp. : 157-162

Informa Healthcare

Access to resources Recommend Favorite

Bowman-Birk protease inhibitor from soybeans enhances cisplatin-induced cytotoxicity in human mesothelioma cells

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 719-724

Spandidos Publications

Access to resources Recommend Favorite

The Bowman-Birk protease inhibitor enhances clonogenic cell survival of ionizing radiation-treated nucleotide excision repair-competent cells but not of xeroderma pigmentosum cells

By Dittmann K. H. Dikomey E. Mayer C. Rodemann H. P.

International Journal of Radiation Biology, Vol. 76, Iss. 2, 2000-02 ,pp. : 223-229

Informa Healthcare

Access to resources Recommend Favorite

Phase I randomized doubleblind placebocontrolled singledose safety studies of BowmanBirk inhibitor concentrate

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 1151-1158

Spandidos Publications

Access to resources Recommend Favorite